Hospital pharmacist challenges in evaluation of scientific evidence and its incorporation to pharmacotherapeutic protocols through therapeutic committees in COVID-19 times
Type 2 coronavirus pandemics that is plaguing almost all the world has caused qualitative and quantitative strains in health systems that have had to be responded to. The lack of known vaccines and effective treatments has generated the need to use drugs with very little evidence for their incorpo...
Saved in:
| Main Authors: | Cecilia M. Fernández-Llamazares, Eduardo López-Briz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-06-01
|
| Series: | Farmacia Hospitalaria |
| Online Access: | http://www.aulamedica.es/fh/pdf/11487.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Incorporation of the hospital pharmacist into the project “Commitment to quality of the Spanish scientific societies
by: María Ángeles Allende-Bandrés, et al.
Published: (2018-01-01) -
Pharmacotherapeutic Options for Ophthalmic Conjunctivitis
by: A. D. van Eyk
Published: (2018-06-01) -
Pharmacotherapeutic Options for Ophthalmic Conjunctivitis
by: A. D. van Eyk
Published: (2019-07-01) -
Pharmacotherapeutics of Musculoskeletal Orofacial Pain
by: Brian E. Cairns, et al.
Published: (2025-12-01) -
Pharmacotherapeutic elements in the osteoarticular algia in dog
by: Calin I. HULEA, et al.
Published: (2018-12-01)